No Data
No Data
No Data
No Data
No Data
Analysts Offer Insights on Healthcare Companies: CalciMedica (CALC), Acrivon Therapeutics, Inc. (ACRV) and Viking Therapeutics (VKTX)
TipRanksApr 25 20:07
CalciMedica Announces Last Patient Enrolled In Phase 2b CARPO Trial Of Auxora In Acute Pancreatitis; Full Target Enrollment Of 216 Patients Achieved
CalciMedica Inc. ("CalciMedica") (NASDAQ:CALC), a clinical-stage biopharmaceutical company focused on developing novel calcium release-activated calcium (CRAC) channel inhibition therapies for acute and chronic inflammatory and immunologic illnesses, today announced that the last patient has been enrolled in its Phase 2b CARPO trial of Auxora in acute pancreatitis (AP).
BenzingaApr 24 20:08
CalciMedica And 2 Other Penny Stocks Insiders Are Buying
The Dow Jones index closed lower by around 400 points on Tuesday. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders
BenzingaApr 3 21:13
CalciMedica Is Maintained at Outperform by Oppenheimer
CalciMedica Is Maintained at Outperform by Oppenheimer
Dow JonesApr 1 21:26
CalciMedica Price Target Maintained With a $14.00/Share by Oppenheimer
CalciMedica Price Target Maintained With a $14.00/Share by Oppenheimer
Dow JonesApr 1 21:26
Top Premarket Decliners
Fractyl Health (GUTS) shares fell 19% Monday premarket after the company reported a wider Q4 net loss. CalciMedica (CALC) shares dropped 18% following a muted session. Vivos Therapeutics (VVOS) shares
MT NewswiresApr 1 20:19
No Data
No Data